Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C

Completed · Phase 2

Conditions studied: Hepatitis C

In brief

Different Doses of rosuvastatin and atorvastatin will be used to see if HCV viral load changes and liver tests change.

Key facts

Study ID

NCT00446940

Run by

Bader, Ted, M.D.

People needed

16

Starts

2006-12-01

Expected to finish

2007-03-01

Last updated by the study team

2008-09-09

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Hepatitis C

You may not qualify if…

• HIV positivity

Where it is running

• VA Hospital — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.